Join to View Full Profile
1 Union StSuite 101Robbinsville, NJ 08691
Phone+1 609-890-7292
Fax+1 215-860-8950
Are you Dr. Singhal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shalabh Singhal, MD is a cardiologist in Robbinsville, New Jersey. He is currently licensed to practice medicine in New Jersey, Ohio, and Pennsylvania.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Cardiovascular Disease, 2006 - 2009
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2003 - 2006
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
SUNY Upstate Medical UniversityClass of 2003
Certifications & Licensure
NJ State Medical License 2013 - 2025
PA State Medical License 2003 - 2016
OH State Medical License 2006 - 2010
Publications & Presentations
PubMed
- Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus.Eric F Morand, Marilyn Pike, J Merrill, Ronald F van Vollenhoven, Victoria P Werth
Expert Opinion on Investigational Drugs. 2024-05-01 - 1 citationsAbsolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans.Anjaneya Chimalakonda, Wenying Li, David Marchisin, Bing He, Shalabh Singhal
Clinical Pharmacology in Drug Development. 2023-10-01 - 100 citationsDeucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.Eric Morand, Marilyn Pike, Joan T Merrill, Ronald van Vollenhoven, Victoria P Werth
Arthritis & Rheumatology. 2023-02-01
